Does CENOBAMATE Cause Product distribution issue? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product distribution issue have been filed in association with CENOBAMATE (Xcopri). This represents 0.1% of all adverse event reports for CENOBAMATE.
7
Reports of Product distribution issue with CENOBAMATE
0.1%
of all CENOBAMATE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product distribution issue From CENOBAMATE?
Of the 7 reports, 5 (71.4%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CENOBAMATE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does CENOBAMATE Cause?
Seizure (1,544)
Product dose omission issue (1,229)
Fatigue (608)
Somnolence (588)
Dizziness (486)
Off label use (376)
Product use issue (364)
Fall (323)
Headache (301)
Wrong technique in product usage process (268)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which CENOBAMATE Alternatives Have Lower Product distribution issue Risk?
CENOBAMATE vs CEPHALEXIN
CENOBAMATE vs CERITINIB
CENOBAMATE vs CERLIPONASE ALFA
CENOBAMATE vs CERTICAN
CENOBAMATE vs CERTOLIZUMAB